Skip to main content
SpringerLink
Log in

Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis

  • Chapter
Neuroblastoma

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 1327 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alaminos M, Mora J, Cheung NK et al. (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63:4538–4546

    PubMed  Google Scholar 

  • Alvarado CS, London WB, Look AT et al. (2000) Natural history and biology of stage A neuroblastoma: a pediatric oncology group study. J Pediatr Hematol Oncol 22:197–205

    Article  PubMed  Google Scholar 

  • Ambros PF, Ambros IM, Strehl S et al. (1995) Regression and progression in neuroblastoma: Does genetics predict tumor behavior? Eur J Cancer 31A:510–515

    Article  PubMed  Google Scholar 

  • Boon K, Caron HN, van Asperen R et al. (2001) N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 20:1383–1393

    Article  PubMed  Google Scholar 

  • Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 761–797

    Google Scholar 

  • Brodeur GM, Seeger RC, Schwab M et al. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stages. Science 224:1121–1124

    PubMed  Google Scholar 

  • Chang NS, Mattison J, Cao H et al. (1998) Cloning and characterization of a novel transforming growth factor-beta 1 induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem Biophys Res Commun 253:743–749

    Article  PubMed  Google Scholar 

  • Choi LMR, Kim NW, Zuo JJ et al. (2000) Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol 35:647–650

    Article  PubMed  Google Scholar 

  • D'Angio GJ, Evans AE, Koop CE (1971) Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1:1046–1049

    Article  PubMed  Google Scholar 

  • George RE, Kenyon RM, McGuckin AG et al. (1996) Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. Oncogene 12:1583–1587

    PubMed  Google Scholar 

  • Grosfeld JL, Rescorla FJ, West KW et al. (1993) Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome. Semin Pediatr Surg 2:37–46

    PubMed  Google Scholar 

  • Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, Sethuraman A, Theesfeld CL, Botstein D, Dolinski K, Feierbach B, Berardini T, Mundodi S, Rhee SY, Apweiler R, Barrell D, Camon E, Dimmer E, Lee V, Chisholm R, Gaudet P, Kibbe W, Kishore R, Schwarz EM, Sternberg P, Gwinn M, Hannick L, Wortman J, Berriman M, Wood V, de la Cruz N, Tonellato P, Jaiswal P, Seigfried T, White R; Gene Ontology Consortium (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258–D261

    Article  PubMed  Google Scholar 

  • Hiemstra JL, Schneider SS, Brodeur GM (1994) High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Prog Clin Biol Res 385:51–57

    PubMed  Google Scholar 

  • Hiyama E, Hiyama K, Nishiyama M et al. (2003) Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J Pediatr Surg 38:1730–1734

    Article  PubMed  Google Scholar 

  • Kushner B, Cheung NK, LaQuaglia M et al. (1996) Survival from locally invasive or metastatic neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373–381

    PubMed  Google Scholar 

  • Ladanyi M, Gerald WL (2003) Expression profiling of human tumors; diagnostic and research applications. Humana Press, Totowa, New Jersey

    Google Scholar 

  • Li Y, Kang J, Horwitz MS (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18:1601–10

    PubMed  Google Scholar 

  • Look AT, Hayes FA, Shuster JJ et al. (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 9:581–591

    PubMed  Google Scholar 

  • Ma A, Moroy T, Collum R et al. (1993) DNA binding by N-and L-Myc proteins. Oncogene 8:1093–1098

    PubMed  Google Scholar 

  • Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a children's cancer group study. J Clin Oncol 16:1256–1264

    PubMed  Google Scholar 

  • Mora J, Cheung NK, Kushner BH et al. (2000) Loss of heterozygosity on chromosome arm 1p correlates with clinical categories of neuroblastoma. J Mol Diagn 2:37–46

    PubMed  Google Scholar 

  • Nisen PD, Waber PG, Rich MA et al. (1988) N-myc oncogene RNA expression in neuroblastoma. J Natl Cancer Inst 80:1633–1637

    PubMed  Google Scholar 

  • Ohira M, Morhashi A, Nakamura Y et al. (2003) Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma. Cancer Lett 197:63–68

    Article  PubMed  Google Scholar 

  • Perez CA, Matthay KK, Atkinson JB et al. (2000) Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol 18:18–26

    PubMed  Google Scholar 

  • Quackenbush J (2001) Computational analysis of microarray data. Nat Rev Genet 2:418–427

    Article  PubMed  Google Scholar 

  • Ramaswamy S, Golub TR (2002) DNA microarrays in clinical oncology. J Clin Oncol 20:1932–1941

    PubMed  Google Scholar 

  • Rust C, Karnitz LM, Paya CV et al. (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275:20210–20216

    Article  PubMed  Google Scholar 

  • Seeger RC, Brodeur GM, Sather H et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116

    PubMed  Google Scholar 

  • Slavc I, Ellenbogen R, Jung WH et al. (1990) myc gene amplification and expression in primary human neuroblastomas. Cancer Res 50:1459–1463

    PubMed  Google Scholar 

  • Su WT, Alaminos M, Mora J, Cheung NK, La Quaglia MP, Gerald WL (2004) Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet 154:131–137

    Article  PubMed  Google Scholar 

  • Sweeney KJ, Clark GD, Prokscha A et al. (2000) Lissencephaly associated mutations suggest a requirement for the PAFAH1B heterotrimeric complex in brain development. Mech Dev 92:263–271

    Article  PubMed  Google Scholar 

  • Van Limpt V, Chan A, Caron H et al. (2000) SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene. Med Pediatr Oncol 35:554–558

    Article  PubMed  Google Scholar 

  • Van Limpt VAE, Chan AJ, van Sluis PG et al. (2003) High delta-like expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 105:61–69

    Article  PubMed  Google Scholar 

  • Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467–478

    Article  PubMed  Google Scholar 

Download references

Authors
  1. William L. Gerald
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Nai-Kong V. Cheung MD, PhD

  2. Department of Pediatrics and the Comprehensive Robert H. Lurie Cancer Center, Northwestern University, 2300 Children's Plaza, Chicago, IL, 60614, USA

    Susan L. Cohn MD

  3. Feinberg School of Medicine, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL, 60614, USA

    Susan L. Cohn MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gerald, W.L. (2005). Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis. In: Cheung, NK.V., Cohn, S.L. (eds) Neuroblastoma. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26616-X_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-26616-X_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40841-3

  • Online ISBN: 978-3-540-26616-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation